These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 34789985

  • 1. Effect of spiramycin versus aminoguanidine and their combined use in experimental toxoplasmosis.
    Omar M, Abaza BE, Mousa E, Ibrahim SM, Rashed HE, Farag TI.
    J Parasit Dis; 2021 Dec; 45(4):1014-1025. PubMed ID: 34789985
    [Abstract] [Full Text] [Related]

  • 2. Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model.
    Zoghroban HS, Elmansory BM, Issa YA, Eltokhy AK, Abo Safia HS, El Maghraby GM, Salama AM.
    Exp Parasitol; 2023 May; 248():108515. PubMed ID: 36958594
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of silver nanoparticles and human platelet rich-plasma versus traditional therapy in the treatment of murine chronic toxoplasmosis.
    Ibrahim SM, Al-Ghandour AMF, Mohamed SMA, Foaad HHM, El-Bahaie ES.
    J Parasit Dis; 2024 Jun; 48(2):217-228. PubMed ID: 38840885
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
    Mady RF, El-Temsahy MM, Issa YA, Zaghloul AS, Khedr SI.
    Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
    [Abstract] [Full Text] [Related]

  • 5. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
    Mohammad OS, El Naggar HM, Abdelmaksoud HF, Barakat AM, Abdelhameed RM, Shehata MAS.
    Acta Trop; 2023 Mar; 239():106823. PubMed ID: 36608751
    [Abstract] [Full Text] [Related]

  • 6. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model.
    Abdel-Wahab AA, Shafey DA, Selim SM, Sharaf SA, Mohsen KK, Allam DM, Elkhadry SW, Gouda MA.
    Parasitol Res; 2024 Jul 24; 123(7):286. PubMed ID: 39046555
    [Abstract] [Full Text] [Related]

  • 7. Application of honeybee venom loaded nanoparticles for the treatment of chronic toxoplasmosis: parasitological, histopathological, and immunohistochemical studies.
    El Naggar HM, Anwar MM, Khayyal AE, Abdelhameed RM, Barakat AM, Sadek SAS, Elashkar AM.
    J Parasit Dis; 2023 Sep 24; 47(3):591-607. PubMed ID: 37520202
    [Abstract] [Full Text] [Related]

  • 8. Zingiber officinale Ameliorates Acute Toxoplasmosis-Induced Pathology in Mice.
    El-Kady AM, Elshazly H, Alsulami MN, Albohiri HH, Alshehri EA, Alfaifi MS, Mohamed K, Wakid MH, Gattan HS, Altwaim SA, Al-Megrin WAI, Almalki GH, Abdel-Rahman IAM, Elshabrawy HA, Younis S.
    Acta Parasitol; 2024 Dec 24; 69(4):1785-1800. PubMed ID: 39225734
    [Abstract] [Full Text] [Related]

  • 9. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.
    Etewa SE, El-Maaty DAA, Hamza RS, Metwaly AS, Sarhan MH, Abdel-Rahman SA, Fathy GM, El-Shafey MA.
    J Parasit Dis; 2018 Mar 24; 42(1):102-113. PubMed ID: 29491568
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
    Allam AF, Hagras NA, Farag HF, Osman MM, Shalaby TI, Kazem AH, Shehab AY, Mogahed NMFH.
    J Parasit Dis; 2022 Mar 24; 46(1):166-177. PubMed ID: 35299902
    [Abstract] [Full Text] [Related]

  • 12. Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis in vivo model and influenced the neuropathological pattern of ME-49 strain.
    Nishi L, Santana PL, Evangelista FF, Beletini LF, Souza AH, Mantelo FM, Souza-Kaneshima AM, Costa IN, Falavigna-Guilherme AL.
    Parasitology; 2020 Mar 24; 147(3):303-309. PubMed ID: 31727196
    [Abstract] [Full Text] [Related]

  • 13. Potential Anti-Toxoplasmosis Efficiency of Phoenix dactylifera Extracts Loaded on Selenium Nanoparticles.
    Wakid MH, Alsulami MN, Farid M, El Kholy WA.
    Infect Drug Resist; 2023 Mar 24; 16():7743-7758. PubMed ID: 38144223
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Investigation of combined effectiveness of spiramycin and beta-glucan in mice models of acute toxoplasmosis and determination of IL-10, IL-12 and TNF-α levels].
    Büyükbaba Boral O, Sönmez Tamer G, Keçeli Özcan S, Sönmez N, Işsever H, Tekeli F.
    Mikrobiyol Bul; 2012 Jul 24; 46(3):446-55. PubMed ID: 22951656
    [Abstract] [Full Text] [Related]

  • 16. A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
    Almurshidi BH, Fahmy Z, El-Shennawy A, Selim EAH, Hammam OA, Okasha H, Al-Hajj W, Mahmoud SA, Abuelenain GL.
    Parasite Immunol; 2023 Dec 24; 45(12):e13014. PubMed ID: 37807942
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Hagras NA, Allam AF, Farag HF, Osman MM, Shalaby TI, Fawzy Hussein Mogahed NM, Tolba MM, Shehab AY.
    Exp Parasitol; 2019 Sep 24; 204():107717. PubMed ID: 31228418
    [Abstract] [Full Text] [Related]

  • 19. Effects of Lactobacilli acidophilus and/or spiramycin as an adjunct in toxoplasmosis infection challenged with diabetes.
    El Saftawy EA, Turkistani SA, Alghabban HM, Albadawi EA, Ibrahim BE, Morsy S, Farag MF, Al Hariry NS, Shash RY, Elkazaz A, Amin NM.
    Food Waterborne Parasitol; 2023 Sep 24; 32():e00201. PubMed ID: 37719029
    [Abstract] [Full Text] [Related]

  • 20. Activity of isoflavone biochanin A in chronic experimental toxoplasmosis: impact on inflammation.
    Aboukamar WA, Elhenawy AA, Elmehankar MS, Elzoheiry MA, El-Gamal R, Elabbasy LM, Hany H, Nabih N.
    Parasitol Res; 2022 Aug 24; 121(8):2405-2414. PubMed ID: 35710847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.